Efficacy of aerosol, intranasal and intramuscular vaccination against selected bovine viral diseases.
An experiment was designed to compare the efficacy of an IM modified live vaccine, an IN temperature-sensitive vaccine, an IN modified live vaccine, and an aerosolized modified live vaccine (two concentrations) to stimulate specific serum antibody and protect calves from a known viral challenge. All vaccines except the IM vaccine contained IBR virus and PI3 virus. The IM vaccine and the IN vaccines provided excellent protection to an IBR challenge, but both concentrations of aerosolized vaccine provided only patial protection. The use of IN modified live vaccine resulted in IBR serum Ab titers in all the test calves (100%), while the IM preparation elicited a response in only 60% of test calves and the IN temperature sensitive vaccine resulted in serum Ab titers in 40% of test calves. The aerosolized vaccine induced IBR serum antibody titers in only 20% of the calves. The use of IN modified live and the aerosolized vaccine resulted in a greater immune response to the PI3 virus (60-80% sero-conversion) than did the temperature sensitive vaccine (20% sero-conversion).
D000281:Administration, Intranasal; D000336:Aerosols; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D002417:Cattle; D007242:Herpesvirus 1, Bovine / Q000276:immunology*; D007241:Infectious Bovine Rhinotracheitis / Q000517:prevention & control*; D007273:Injections, Intramuscular; D014611:Vaccination / Q000662:veterinary*; D014765:Viral Vaccines / Q000008:administration & dosage*
D000336:Aerosols; D000914:Antibodies, Viral; D014765:Viral Vaccines